GOLDMAN SACHS GROUP INC

Filings at 1 company/Other · Attovia Therapeutics, Inc.

5 of 64 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 64. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 64 visible filings, newest first.

Attovia Therapeutics, Inc. Other
$121,888Open-market buy
TradedAug 5, 2026FiledAug 28, 2026
Attovia Therapeutics, Inc. Other
$242,435Open-market buy
TradedAug 5, 2026FiledAug 28, 2026
Attovia Therapeutics, Inc. Other
$969,657Open-market buy
TradedAug 5, 2026FiledAug 28, 2026
Attovia Therapeutics, Inc. Other
$243,775Open-market buy
TradedAug 5, 2026FiledAug 28, 2026
Attovia Therapeutics, Inc. Other
$609,375Open-market buy
TradedAug 5, 2026FiledAug 28, 2026